tiprankstipranks
Trending News
More News >
Ligand Pharmaceuticals Inc (DE:LGDN)
:LGDN
Advertisement

Ligand Pharma (LGDN) Similar Stocks

Compare
1 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Ligand Pharma
€153.00
€3.01B
49.85
61.50%
6 Buy
0 Hold
0 Sell
Strong Buy
Apellis Pharmaceuticals
$23.15
$3.17B
-15.45%
11 Buy
6 Hold
1 Sell
Moderate Buy
Scholar Rock Holding
$34.28
$3.79B
11.77%
13 Buy
0 Hold
0 Sell
Strong Buy
Crinetics Pharmaceuticals
$44.43
$4.23B
-16.33%
15 Buy
1 Hold
0 Sell
Strong Buy
Kymera Therapeutics
$59.89
$4.09B
30.04%
17 Buy
0 Hold
0 Sell
Strong Buy
MoonLake Immunotherapeutics
$10.66
$659.01M
-78.88%
8 Buy
8 Hold
1 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:LGDN
Ligand Pharma
151.00
57.00
60.64%
APLS
Apellis Pharmaceuticals
23.15
-4.80
-17.17%
SRRK
Scholar Rock Holding
31.90
3.36
11.77%
CRNX
Crinetics Pharmaceuticals
44.43
-13.17
-22.86%
KYMR
Kymera Therapeutics
58.26
13.46
30.04%
MLTX
MoonLake Immunotherapeutics
10.14
-37.86
-78.88%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis